NxStage MedicalInc. (NASDAQ: NXTM)创立于1998年,总部位于美国波士顿,雇员约3400人。公司主要从事治疗肾功能衰竭、体液过量及与血液相关的处理机制、程序等医疗设备/仪器产品的开发、制造和销售,主要产品包括:System One (便携式血液透析系统,主要用于家庭用血透服务...
Even with long delays, NxStage investors seem to be confident that the Fresenius acquisition will go through. Currently, the share price is just 3% below the $30-per-share takeover price, and that's down from around 5% to 6% during the summer months. In late October, NxStage filed with...